Robert Swift conducts clinical and laboratory research on the causes of and treatments for alcoholism and drug dependence. He is particularly interested in how medications act to reduce craving and other potential endophenotypes of addictive disorders. He conducts clincal trials in patients with substance use disorders to investigate the efficacy of medications alone as well as medications combined with non-medical treatments such as counseling. He is also interested in the adoption of these new medications into medical practice.
Dr. Swift received his B.A., Ph.D. and M.D.(with honors)degrees from the University of Chicago. He completed a residency in Psychiatry at Yale University and is Board Certified in Adult Psychiatry and in Addiction Psychiatry. He conducts clinical and laboratory research on the pharmacological treatment of alcohol and drug abuse and dependence. He is a recipient of research grants from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Drug Abuse (NIDA) and from foundations and pharmaceutical companies. He has been the site Principal Investigator for several industry and NIH sponsored clinical trials of addiction treatments, including the NIAAA COMBINE Study, a cooperative clinical trial investigating combined pharmacotherapy and psychotherapy in the treatment of alcohol dependence. He serves frequently as a member of advisory committees to government agencies and industry. He is a Distinguished Fellow of the American Psychiatric Association (APA), a fellow of the American College of Neuropsychopharmacology (ACNP), and a regular member of the Neural Basis of Psychopathology, Addiction and Sleep (NPAS) grant review committee at the NIH. Dr. Swift is the Associate Chief of Staff for Research at the Providence VA Medical Center, where he directs a growing Research Service.
ROBERT SWIFT, M.D., Ph.D.
Collaborators at other institutions:
Are you Robert Swift? Click here to edit your research profile.